Cardiome Gets Lifeline with Merck Deal
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 4 (Table of Contents)
Published: 10 Apr-2009
DOI: 10.3833/pdr.v2009.i4.1091 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Cardiome Pharma has signed an agreement with Merck and Co Inc to jointly develop vernakalant, a experimental drug to treat atrial fibrillation, in a deal that could be worth more than US$600 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS